On June 30, 2025, Aptevo Therapeutics Inc. reported that it believes it is compliant with Nasdaq's listing requirements after raising approximately $15.9 million in equity capital, surpassing the $2.5 million minimum stockholders' equity requirement. This compliance followed several successful stock offerings between April and June 2025.